Synapse Open Synapse
Biology

Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3)

Labiotech.eu · · 1 min read

In part three of our series, I spoke with Ryan Confer, President and CEO of Genprex, about the company’s move from cancer into diabetes.

Latest from Labiotech.eu